Inflammation as a Target and a Marker of Disease Severity in Coronary Artery Disease


Dr. Tamar Polonsky, assistant professor of medicine, discusses the key factors associated with coronary artery disease and inflammation and addresses the following questions:
- Would treatment with a potent anti-inflammatory medication, in addition to usual care, reduce cardiovascular events?
- Should we measure inflammatory markers to track response to statin therapy?
- Can hsCRP be used to help guide decisions about when to initiate statin therapy for primary prevention?



Tamar Polonsky

Tamar Polonsky, MD

Tamar Polonsky, MD Assistant Professor of Medicine

Admissions, Referrals and Consultations:

Call UCM Physician Connect at
Contact Us